Similar articles for PMID: 24324087

Year	Number of Results
1993	1
1999	1
2002	1
2003	1
2004	2
2005	8
2006	5
2007	5
2008	3
2009	5
2010	3
2011	4
2012	8
2013	8
2014	7
2015	4
2016	8
2017	2
2018	3
2019	4
2020	4
2022	1
2023	1
2024	2
2025	0

1

Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial.

Coosemans A, Vanderstraeten A, Tuyaerts S, Verschuere T, Moerman P, Berneman ZN, Vergote I, Amant F, VAN Gool SW. Coosemans A, et al. Anticancer Res. 2013 Dec;33(12):5495-500. Anticancer Res. 2013. PMID: 24324087 Clinical Trial.

2

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.

Coosemans A, Vanderstraeten A, Tuyaerts S, Verschuere T, Moerman P, Berneman Z, Vergote I, Amant F, Van Gool SW. Coosemans A, et al. Anticancer Res. 2013 Sep;33(9):3855-9. Anticancer Res. 2013. PMID: 24023319

3

Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma.

Coosemans A, Wölfl M, Berneman ZN, Van Tendeloo V, Vergote I, Amant F, Van Gool SW. Coosemans A, et al. Anticancer Res. 2010 Sep;30(9):3709-14. Anticancer Res. 2010. PMID: 20944158

4

Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.

Sakai K, Shimodaira S, Maejima S, Udagawa N, Sano K, Higuchi Y, Koya T, Ochiai T, Koide M, Uehara S, Nakamura M, Sugiyama H, Yonemitsu Y, Okamoto M, Hongo K. Sakai K, et al. J Neurosurg. 2015 Oct;123(4):989-97. doi: 10.3171/2015.1.JNS141554. Epub 2015 Aug 7. J Neurosurg. 2015. PMID: 26252465 Clinical Trial.

5

Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.

Smits EL, Stein B, Nijs G, Lion E, Van Tendeloo VF, Willemen Y, Anguille S, Berneman ZN. Smits EL, et al. Methods Mol Biol. 2016;1393:27-35. doi: 10.1007/978-1-4939-3338-9_3. Methods Mol Biol. 2016. PMID: 27033213

6

Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.

Kamigaki T, Kaneko T, Naitoh K, Takahara M, Kondo T, Ibe H, Matsuda E, Maekawa R, Goto S. Kamigaki T, et al. Anticancer Res. 2013 Jul;33(7):2971-6. Anticancer Res. 2013. PMID: 23780988 Clinical Trial.

7

Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.

Van Genechten T, De Laere M, Van den Bossche J, Stein B, De Rycke K, Deschepper C, Hazes K, Peeters R, Couttenye MM, Van De Walle K, Roelant E, Maes S, Vanden Bossche S, Dekeyzer S, Huizing M, Caluwaert K, Nijs G, Cools N, Verlooy J, Norga K, Verhulst S, Anguille S, Berneman Z, Lion E. Van Genechten T, et al. BMJ Open. 2024 Mar 18;14(3):e077613. doi: 10.1136/bmjopen-2023-077613. BMJ Open. 2024. PMID: 38503417 Free PMC article.

8

[Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].

Gu WY, Cao XS, Qiu GQ, Chen ZX, Sheng LX, Xie XB, He J, Cen JN, Shen HL. Gu WY, et al. Zhonghua Yi Xue Za Zhi. 2005 Dec 28;85(49):3475-80. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16686063 Chinese.

9

Targeting of the WT1_91-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.

Dagvadorj N, Deuretzbacher A, Weisenberger D, Baumeister E, Trebing J, Lang I, Köchel C, Kapp M, Kapp K, Beilhack A, Hünig T, Einsele H, Wajant H, Grigoleit GU. Dagvadorj N, et al. Cancer Immunol Immunother. 2017 Mar;66(3):319-332. doi: 10.1007/s00262-016-1938-y. Epub 2016 Nov 28. Cancer Immunol Immunother. 2017. PMID: 27896368 Free PMC article.

10

Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.

May RJ, Dao T, Pinilla-Ibarz J, Korontsvit T, Zakhaleva V, Zhang RH, Maslak P, Scheinberg DA. May RJ, et al. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4547-55. doi: 10.1158/1078-0432.CCR-07-0708. Clin Cancer Res. 2007. PMID: 17671141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 24324087

84 results

Results by year